Brought to you by 
Baxter acquires Synovis Life Technologies for $312.7mm in cash
16 Dec 2011
Executive Summary
In its third acquisition of 2011, Baxter International Inc. is acquiring public Synovis Life Technologies Inc. (surgical devices for soft tissue repair) for $312.7mm in cash, or $28 per share (a 52% premium). Synovis will become part of Baxter BioScience, a division of Baxter Healthcare Corp.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Surgical Sealants
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter acquires Synovis Life Technologies for $312.7mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice